4-Methylphenmetrazine
4-Methylphenmetrazine (4-MPM) is a psychoactive drug and research chemical belonging to the phenmetrazine class of compounds. Phenmetrazine itself was once a popular stimulant drug prescribed for the treatment of obesity, but due to issues of abuse, it was withdrawn from the market. 4-Methylphenmetrazine is one of the derivatives synthesized in an attempt to find new therapeutic agents with potentially fewer side effects and lower abuse potential.
Chemistry[edit | edit source]
4-Methylphenmetrazine is a synthetic molecule of the amphetamine family. Structurally, it is related to phenmetrazine, differing by the addition of a methyl group at the 4th position of the phenyl ring. This modification is thought to influence its pharmacological properties, although the exact effects of this substitution on the drug's activity are not fully understood.
Pharmacology[edit | edit source]
The pharmacological action of 4-Methylphenmetrazine is primarily that of a central nervous system stimulant. It is believed to work by promoting the release of dopamine and norepinephrine, two key neurotransmitters involved in regulating mood and energy levels. However, detailed studies on its mechanism of action are limited, and much of what is known comes from extrapolation from other similar compounds.
Legal Status[edit | edit source]
The legal status of 4-Methylphenmetrazine varies by country, but it is often classified as a controlled substance or research chemical, making its possession without proper authorization illegal. This classification is due to its potential for abuse, addiction, and the lack of established medical use.
Health Risks[edit | edit source]
As with other stimulants, the use of 4-Methylphenmetrazine can pose significant health risks. These may include psychosis, cardiovascular disease, and neurotoxicity. The risk of adverse effects may be higher with unregulated research chemicals, as their purity and composition can vary widely.
Conclusion[edit | edit source]
While 4-Methylphenmetrazine may have potential research value in understanding the pharmacology of stimulants, its use outside of controlled settings is highly discouraged due to the significant health risks and legal issues associated with its possession and use.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
